£520.00

It has never been this cheap. We have no record of a lower price.

£520 today · cheaper than every other day in the last 3 months

Alpha-1 Antitrypsin Deficiency Treatment Outlook 2023-2028

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 23 days · 23 data points (no recent data)

Historical
Generating forecast…
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 11 August 2026 16 August 2026 22 August 2026 27 August 2026 02 September 2026
View at Amazon ↗

Price data last checked 68 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 23 days • 1 price levels

Days at Price
23 days 0 6 12 17 23 £520 Days at Price

Price Analysis

Most common price: £520 (23 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 23 days

Description

This comprehensive study provides a detailed outlook for Alpha-1 antitrypsin deficiency treatments in the United States from 2023 to 2028. It focuses on latent demand estimates, also known as potential industry earnings (P.I.E.), across approximately 12,600 cities. By analyzing data at the state and city levels, the report offers a granular view of market opportunities throughout the country. Users can access the percent share each city holds in relation to its state and the United States as a whole. These comparative benchmarks enable professionals to evaluate specific locations against others quickly. This statistical approach serves as a practical tool for developing effective distribution and sales force strategies based on localized demand data.

Key Features

Provides latent demand outlook and potential industry earnings (P.I.E.) estimates for Alpha-1 antitrypsin deficiency treatments.

Covers market data across approximately 12,600 cities within the United States.

Includes comparative benchmarks showing each city's percent share of its state and the total U.S. market.

Offers statistical insights designed to assist with distribution and sales force strategies.

Delivers a detailed market outlook spanning the years 2023 through 2028.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
09 November 2022

Similar Products You Might Like

Alpha-1 Antitrypsin Deficiency Treatment Outlook 2023-2028
99% match

Alpha-1 Antitrypsin Deficiency Treatment Outlook 2023-2028

£520.00 03 Sep 2026
Alpha-1 Antitrypsin Deficiency Treatment Outlook in India
99% match

Alpha-1 Antitrypsin Deficiency Treatment Outlook in India

£515.00 02 Sep 2026
Alpha-1 Antitrypsin Deficiency Treatment Outlook in India
99% match

Alpha-1 Antitrypsin Deficiency Treatment Outlook in India

£515.00 03 Sep 2026
World Outlook: Alpha-1 Antitrypsin Deficiency Treatments
99% match

World Outlook: Alpha-1 Antitrypsin Deficiency Treatments

£790.00 28 Aug 2026
The 2026-2031 World Outlook for Alpha-1 Antitrypsin Deficiency Treatments
99% match

The 2026-2031 World Outlook for Alpha-1 Antitrypsin Deficiency Treatments

£885.00 27 Aug 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in China
99% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in China

£495.00 28 Oct 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in Japan
99% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in Japan

£495.00 02 Nov 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in China
98% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in China

£495.00 30 Sep 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in Japan
98% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in Japan

£495.00 07 Nov 2026
Alpha-1 Antitrypsin Deficiency Treatment Outlook 2023-2028
98% match

Alpha-1 Antitrypsin Deficiency Treatment Outlook 2023-2028

£490.00 24 Aug 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies for US Zip Codes
98% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies for US Zip Codes

£490.00 01 Oct 2026
Alpha-1 Antitrypsin Drug Outlook 2023-2028 US Zip Codes
98% match

Alpha-1 Antitrypsin Drug Outlook 2023-2028 US Zip Codes

£490.00 26 Aug 2026
US Air Treatment Products Outlook 2023-2028 Study
97% match

US Air Treatment Products Outlook 2023-2028 Study

£520.00 24 Aug 2026
The 2023 Report on Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies: World Market Segmentation by City
97% match

The 2023 Report on Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies: World Market Segmentation by City

£795.00 01 Sep 2026
Pulmonary Fibrosis Treatment Outlook 2023-2028 - US Study
97% match

Pulmonary Fibrosis Treatment Outlook 2023-2028 - US Study

£520.00 05 Nov 2026
Air Treatment Products in India 2023-2028 Outlook Study
97% match

Air Treatment Products in India 2023-2028 Outlook Study

£515.00 02 Nov 2026
US Animal Health API Outlook 2023-2028 Report
97% match

US Animal Health API Outlook 2023-2028 Report

£520.00 03 Sep 2026
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in India
97% match

The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in India

£515.00 02 Sep 2026
Anti-Inflammatory Asthma Drugs Outlook 2023-2028 Report
97% match

Anti-Inflammatory Asthma Drugs Outlook 2023-2028 Report

£520.00 03 Sep 2026
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in India
96% match

The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in India

£515.00 02 Sep 2026
Hepatitis C Virus (HCV) Therapeutics Outlook 2016-2021 Study
96% match

Hepatitis C Virus (HCV) Therapeutics Outlook 2016-2021 Study

£595.00 28 Oct 2026
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
96% match

The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£595.00 04 Nov 2026
2023-2028 US Advanced Therapy Medicinal Products Outlook
96% match

2023-2028 US Advanced Therapy Medicinal Products Outlook

£520.00 05 Nov 2026
US Automotive Air Filter Outlook 2023-2028 Market Study
96% match

US Automotive Air Filter Outlook 2023-2028 Market Study

£520.00 04 Nov 2026